| 1 | favorable | 5,208 |
| 2 | favourable | 2,130 |
| 3 | unfavorable | 1,035 |
| 4 | unfavourable | 466 |
| 5 | placebo-like | 23 |
| 6 | pejorative | 11 |
| 7 | demonstrative | 10 |
| 8 | button-press | 7 |
| 9 | high/medium | 6 |
| 10 | inhospitable | 5 |
| 11 | atheropreventive | 3 |
| 12 | graver | 3 |
| 13 | hyperaccentuated | 3 |
| 14 | less-favorable | 3 |
| 15 | neandertal | 3 |
| 16 | non-computerized | 3 |
| 17 | shortand | 3 |
| 18 | anti-thermal | 2 |
| 19 | antinidatory | 2 |
| 20 | bubble-like | 2 |
| 21 | carcinological | 2 |
| 22 | dysgeusic | 2 |
| 23 | hormetic-like | 2 |
| 24 | mvoi-related | 2 |
| 25 | network-specific | 2 |
| 26 | 1000-h | 1 |
| 27 | additivity-based | 1 |
| 28 | ameijeiras | 1 |
| 29 | calpers | 1 |
| 30 | chiroablative | 1 |
| 31 | commonly-measured | 1 |
| 32 | dominant/aggressive | 1 |
| 33 | dose-concentration-dependent | 1 |
| 34 | double-digital | 1 |
| 35 | equable | 1 |
| 36 | favolable | 1 |
| 37 | favourabale | 1 |
| 38 | frequently-observed | 1 |
| 39 | gpat4-derived | 1 |
| 40 | hoarseness-related | 1 |
| 41 | included.primary | 1 |
| 42 | interval/ratio | 1 |
| 43 | lender-owned | 1 |
| 44 | lilly-maintained | 1 |
| 45 | medication.the | 1 |
| 46 | monolingual-like | 1 |
| 47 | noncompartment | 1 |
| 48 | null/trivial | 1 |
| 49 | parkisonian-like | 1 |
| 50 | permission.the | 1 |
| 51 | pharmacokinetic-viral | 1 |
| 52 | pin-on-disk | 1 |
| 53 | pre-cpr | 1 |
| 54 | prognatic | 1 |
| 55 | quasilocal | 1 |
| 56 | rdx-laden | 1 |
| 57 | recently-completed | 1 |
| 58 | ritonavir-based | 1 |
| 59 | side-adverse | 1 |
| 60 | small-strain | 1 |
| 61 | structure/tissue-related | 1 |
| 62 | th2-dominated | 1 |
| 63 | transport-property | 1 |
| 64 | two-mass | 1 |
| 65 | violence-supportive | 1 |
| 66 | well-deserved | 1 |
| 67 | whole-sediment | 1 |
| 1 | 1000-h | 1 |
| 2 | additivity-based | 1 |
| 3 | ameijeiras | 1 |
| 4 | anti-thermal | 2 |
| 5 | antinidatory | 2 |
| 6 | atheropreventive | 3 |
| 7 | bubble-like | 2 |
| 8 | button-press | 7 |
| 9 | calpers | 1 |
| 10 | carcinological | 2 |
| 11 | chiroablative | 1 |
| 12 | commonly-measured | 1 |
| 13 | demonstrative | 10 |
| 14 | dominant/aggressive | 1 |
| 15 | dose-concentration-dependent | 1 |
| 16 | double-digital | 1 |
| 17 | dysgeusic | 2 |
| 18 | equable | 1 |
| 19 | favolable | 1 |
| 20 | favorable | 5,208 |
| 21 | favourabale | 1 |
| 22 | favourable | 2,130 |
| 23 | frequently-observed | 1 |
| 24 | gpat4-derived | 1 |
| 25 | graver | 3 |
| 26 | high/medium | 6 |
| 27 | hoarseness-related | 1 |
| 28 | hormetic-like | 2 |
| 29 | hyperaccentuated | 3 |
| 30 | included.primary | 1 |
| 31 | inhospitable | 5 |
| 32 | interval/ratio | 1 |
| 33 | lender-owned | 1 |
| 34 | less-favorable | 3 |
| 35 | lilly-maintained | 1 |
| 36 | medication.the | 1 |
| 37 | monolingual-like | 1 |
| 38 | mvoi-related | 2 |
| 39 | neandertal | 3 |
| 40 | network-specific | 2 |
| 41 | non-computerized | 3 |
| 42 | noncompartment | 1 |
| 43 | null/trivial | 1 |
| 44 | parkisonian-like | 1 |
| 45 | pejorative | 11 |
| 46 | permission.the | 1 |
| 47 | pharmacokinetic-viral | 1 |
| 48 | pin-on-disk | 1 |
| 49 | placebo-like | 23 |
| 50 | pre-cpr | 1 |
| 51 | prognatic | 1 |
| 52 | quasilocal | 1 |
| 53 | rdx-laden | 1 |
| 54 | recently-completed | 1 |
| 55 | ritonavir-based | 1 |
| 56 | shortand | 3 |
| 57 | side-adverse | 1 |
| 58 | small-strain | 1 |
| 59 | structure/tissue-related | 1 |
| 60 | th2-dominated | 1 |
| 61 | transport-property | 1 |
| 62 | two-mass | 1 |
| 63 | unfavorable | 1,035 |
| 64 | unfavourable | 466 |
| 65 | violence-supportive | 1 |
| 66 | well-deserved | 1 |
| 67 | whole-sediment | 1 |
| 1 | network-specific | 2 |
| 2 | dysgeusic | 2 |
| 3 | prognatic | 1 |
| 4 | lilly-maintained | 1 |
| 5 | lender-owned | 1 |
| 6 | commonly-measured | 1 |
| 7 | ritonavir-based | 1 |
| 8 | additivity-based | 1 |
| 9 | structure/tissue-related | 1 |
| 10 | mvoi-related | 2 |
| 11 | hoarseness-related | 1 |
| 12 | th2-dominated | 1 |
| 13 | hyperaccentuated | 3 |
| 14 | recently-completed | 1 |
| 15 | gpat4-derived | 1 |
| 16 | frequently-observed | 1 |
| 17 | well-deserved | 1 |
| 18 | non-computerized | 3 |
| 19 | shortand | 3 |
| 20 | permission.the | 1 |
| 21 | medication.the | 1 |
| 22 | hormetic-like | 2 |
| 23 | bubble-like | 2 |
| 24 | monolingual-like | 1 |
| 25 | parkisonian-like | 1 |
| 26 | placebo-like | 23 |
| 27 | favourabale | 1 |
| 28 | favolable | 1 |
| 29 | favorable | 5,208 |
| 30 | less-favorable | 3 |
| 31 | unfavorable | 1,035 |
| 32 | favourable | 2,130 |
| 33 | unfavourable | 466 |
| 34 | inhospitable | 5 |
| 35 | equable | 1 |
| 36 | side-adverse | 1 |
| 37 | dominant/aggressive | 1 |
| 38 | chiroablative | 1 |
| 39 | pejorative | 11 |
| 40 | demonstrative | 10 |
| 41 | atheropreventive | 3 |
| 42 | violence-supportive | 1 |
| 43 | 1000-h | 1 |
| 44 | pin-on-disk | 1 |
| 45 | carcinological | 2 |
| 46 | quasilocal | 1 |
| 47 | null/trivial | 1 |
| 48 | anti-thermal | 2 |
| 49 | pharmacokinetic-viral | 1 |
| 50 | double-digital | 1 |
| 51 | neandertal | 3 |
| 52 | high/medium | 6 |
| 53 | rdx-laden | 1 |
| 54 | small-strain | 1 |
| 55 | interval/ratio | 1 |
| 56 | graver | 3 |
| 57 | pre-cpr | 1 |
| 58 | ameijeiras | 1 |
| 59 | calpers | 1 |
| 60 | two-mass | 1 |
| 61 | button-press | 7 |
| 62 | dose-concentration-dependent | 1 |
| 63 | whole-sediment | 1 |
| 64 | noncompartment | 1 |
| 65 | included.primary | 1 |
| 66 | antinidatory | 2 |
| 67 | transport-property | 1 |